We are live on ! Find out more
BFM

Boothbay Fund Management Portfolio holdings

AUM $7.71B
1-Year Est. Return 106.29%
This Fund
S&P 500
This Quarter Est. Return
+5.34%
1 Year Est. Return
+106.29%
3 Year Est. Return
+266.67%
5 Year Est. Return
+310.43%
10 Year Est. Return
+1,579.99%
AUM
$4.32B
AUM Growth
+$316M
Cap. Flow
-$173M
Cap. Flow %
-4%
Top 10 Hldgs %
10.31%
Holding
2,841
New
651
Increased
541
Reduced
445
Closed
892

Sector Composition

Rank Sector Weight
1 Financials 12.96%
2 Healthcare 8.24%
3 Technology 8.23%
4 Industrials 6.13%
5 Consumer Discretionary 5.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRN
1701
DELISTED
Veren
VRN
$118K ﹤0.01%
16,461
-2,865
-15% -$21.3K
RLJ icon
1702
RLJ Lodging Trust
RLJ
$1.75B
$117K ﹤0.01%
+11,047
New +$125K
BFIIW
1703
DELISTED
BurgerFi International, Inc. Warrant
BFIIW
$116K ﹤0.01%
92,342
-3,720
-4% -$426
PLTR icon
1704
Palantir
PLTR
$409B
$115K ﹤0.01%
+17,981
New +$136K
AGS
1705
DELISTED
PlayAGS
AGS
$115K ﹤0.01%
+22,547
New +$127K
TUSK icon
1706
Mammoth Energy Services
TUSK
$158M
$115K ﹤0.01%
+13,270
New +$75.6K
IMTXW
1707
DELISTED
Immatics N.V. Warrants
IMTXW
$115K ﹤0.01%
13,166
EFHTR
1708
DELISTED
EF Hutton Acquisition Corporation I Rights
EFHTR
$114K ﹤0.01%
+915,750
New +$119K
ETRN
1709
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
$114K ﹤0.01%
+16,997
New +$132K
ACTG icon
1710
Acacia Research
ACTG
$461M
$114K ﹤0.01%
27,000
+2,675
+11% +$10.5K
CLINR
1711
DELISTED
Clean Earth Acquisitions Corp. Right
CLINR
$114K ﹤0.01%
884,460
+184,460
+26% +$26.1K
CBAY
1712
DELISTED
Cymabay Therapeutics
CBAY
$113K ﹤0.01%
+18,071
New +$68.7K
PSQH.WS icon
1713
PSQ Holdings, Inc. Warrants, Each whole warrant exercisable for 1/15th of a share of Class A common stock at an exercise price of $172.50 per share
PSQH.WS
$1.73M
$113K ﹤0.01%
+11,380
New +$825
WVE icon
1714
Wave Life Sciences
WVE
$1.18B
$113K ﹤0.01%
+16,100
New +$74.2K
GENI.WS
1715
DELISTED
Genius Sports Limited Redeemable Warrants, each whole warrant exercisable for one Ordinary Share each at an exercise price of $11. 50 per share
GENI.WS
$111K ﹤0.01%
+31,206
New +$30.7K
IRAAW
1716
DELISTED
Iris Acquisition Corp Warrant
IRAAW
$110K ﹤0.01%
+10,917
New +$525
NSTD.WS
1717
DELISTED
Northern Star Investment Corp. IV Redeemable Warrants, each whole warrant exercisable for shares of Class A common stock at an exercise price of $11.50 per share
NSTD.WS
$109K ﹤0.01%
+10,864
New +$338
JELD icon
1718
JELD-WEN Holding
JELD
$165M
$109K ﹤0.01%
11,299
-7,088
-39% -$68.8K
LYRA
1719
DELISTED
LYRA THERAPEUTICS INC
LYRA
$109K ﹤0.01%
694
EMKR
1720
DELISTED
Emcore Corp
EMKR
$109K ﹤0.01%
+11,323
New +$162K
ACAXR
1721
DELISTED
Alset Capital Acquisition Corp Right
ACAXR
$109K ﹤0.01%
725,000
HT
1722
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
$108K ﹤0.01%
+12,693
New +$114K
BGFV
1723
DELISTED
Big 5 Sporting Goods
BGFV
$108K ﹤0.01%
+12,216
New +$140K
CNCE
1724
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$108K ﹤0.01%
+18,414
New +$96.8K
WTMAR
1725
DELISTED
Welsbach Technology Metals Acquisition Corp. one right to receive 1/10th of a share of common stock
WTMAR
$107K ﹤0.01%
621,600

Similar funds

Boothbay Fund Management's Q4 2022 Portfolio in Review

As of Q4 2022, Boothbay Fund Management held 2,841 positions worth $4.32B, up 7.9% from $4.01B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Boothbay Fund Management withdrew a net $173M in Q4 2022, closing 892 positions and reducing 445 holdings. Its most notable exit was Alleghany Corp, an estimated $20.1M position sold in full.

By sector, the portfolio is most concentrated in Financials at 13% of assets, down from 15% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Boothbay Fund Management opened a new position in Kairos Acquisition Corp. Class A Ordinary Shares worth $12.6M.

  • Boothbay Fund Management's largest Q4 2022 buy was Kairos Acquisition Corp. Class A Ordinary Shares: 1,255,444 shares worth $12.6M.
  • Boothbay Fund Management added most to RMG Acquisition Corp. III Class A Ordinary Shares in Q4 2022, an estimated $19.5M increase.
  • Boothbay Fund Management's biggest Q4 2022 reduction was ADMA Biologics, cutting an estimated $21.8M.
  • Boothbay Fund Management fully exited Alleghany Corp in Q4 2022, selling an estimated $20.1M.
  • Boothbay Fund Management's ten largest holdings make up 10% of its $4.32B portfolio in Q4 2022.
  • Boothbay Fund Management opened 651 new positions and closed 892 in Q4 2022.
  • Boothbay Fund Management's portfolio value rose 7.9% quarter-over-quarter to $4.32B.

Based on Boothbay Fund Management's 13F filing for Q4 2022, filed 14 Feb 2023.